PairX Bio

PairX Bio is at the forefront of biotechnology research, dedicated to pioneering the development of next-generation cancer-selective biologics. By identifying novel, highly prevalent, tumor-selective cell surface variants, PairX Bio employs a biology-driven approach to reveal a new class of therapeutic targets, paired with a variety of optimal therapeutic modalities.

With intellectual property exclusively licensed from Duke-NUS Medical School, Singapore, PairX Bio is advancing a robust pipeline of potential first- and best-in-class tumor-selective therapies. These therapies target prevalent cancers in substantial patient populations, promising significant advancements in oncology. The primary location for PairX Bio is 21 Biopolis Road, Singapore, 138567, SG.

PairX Bio is committed to improving patient outcomes through innovative and targeted therapies. We invite the manager of PairX Bio to create a customized and exclusive company showcase and product listing on our platform, further highlighting your contributions to the biotechnology field.